Next generation dengue vaccines: A review of candidates in preclinical development

Julia Schmitz, John Roehrig, Alan Barrett, Joachim Hombach

Research output: Contribution to journalArticlepeer-review

90 Scopus citations


Dengue represents a major public health problem of growing global importance. In the absence of specific dengue therapeutics, strategies for disease control have increasingly focused on the development of dengue vaccines. While a licensed dengue vaccine is not yet available, several vaccine candidates are currently being evaluated in clinical trials and are described in detail in accompanying articles. In addition, there are a large variety of candidates in preclinical development, which are based on diverse technologies, ensuring a continued influx of innovation into the development pipeline. Potentially, some of the current preclinical candidates may become next generation dengue vaccines with superior product profiles. This review provides an overview of the various technological approaches to dengue vaccine development and specifically focuses on candidates in preclinical development.

Original languageEnglish (US)
Pages (from-to)7276-7284
Number of pages9
Issue number42
StatePublished - Sep 23 2011


  • Dengue
  • Dengue vaccines
  • Dengue virus

ASJC Scopus subject areas

  • Molecular Medicine
  • General Immunology and Microbiology
  • General Veterinary
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases


Dive into the research topics of 'Next generation dengue vaccines: A review of candidates in preclinical development'. Together they form a unique fingerprint.

Cite this